# clm_DBECC41209EA

subject: Amgen (/record/amgen.md)  
predicate: quarterly_operating_income  
value: 3,514,000,000 United States dollar  
valid_from: 2026-06-30  
valid_to: 2026-09-30  
published: 2026-08-05  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_B7EB0BB6DBEB  
last_updated: 2026-11-08  
cite: AsOf. "Amgen quarterly operating income: 3,514,000,000 United States dollar", as of 2026-06-30 (until 2026-09-30). Claim clm_DBECC41209EA, https://asof.is/claim/clm_DBECC41209EA, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/0000318154-26-000126-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2026, filed 2026-08-05  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/0000318154-26-000126-index.htm (primary, SEC EDGAR 10-Q Q2 FY2026, published 2026-08-05)

## Supersedes

- [Amgen](/record/amgen.md) | quarterly_operating_income | 2,666,000,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_DBECC41209EA](/claim/clm_DBECC41209EA.md) | [clm_8FA61AE28EA3](/claim/clm_8FA61AE28EA3.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.
